EUVIMEDEUVIMED entdecken
Open Access

SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia

Céline Moison iD, Deanne Gracias, Julie Schmitt, Simon Girard, Jean-François Spinella, Simon Fortier iD, Isabel Boivin iD, Rodrigo Mendoza-Sanchez iD, Bounkham Thavonekham, Tara MacRae iD, Nadine Mayotte iD, Eric Bonneil iD und 7 weitere

Science Advances · 22.03.2024 · 10 (12)

DOI: 10.1126/sciadv.adl4018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 22.03.2024. Verfasst von Céline Moison und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada. Hauptthemen laut MEDLINE: Copper, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a phenotypical screen of 56 acute myeloid leukemia (AML) patient samples and using a library of 10,000 compounds, we identified a hit with increased sensitivity toward SF3B1 -mutated and adverse risk AMLs. Through structure-activity relationship studies, this hit was optimized into a potent, specific, and nongenotoxic molecule called UM4118. We demonstrated that UM4118 acts as a copper ionophore that initiates a mitochondrial-based noncanonical form of cell death known as cuproptosis. CRISPR-Cas9 loss-of-function screen further revealed that iron-sulfur cluster (ISC) deficiency enhances copper-mediated cell death. Specifically, we found that loss of the mitochondrial ISC transporter ABCB7 is synthetic lethal to UM4118. ABCB7 is misspliced and down-regulated in SF3B1 -mutated leukemia, creating a vulnerability to copper ionophores. Accordingly, ABCB7 overexpression partially rescued SF3B1 -mutated cells to copper overload. Together, our work provides mechanistic insights that link ISC deficiency to cuproptosis, as exemplified by the high sensitivity of SF3B1 -mutated AMLs. We thus propose SF3B1 mutations as a biomarker for future copper ionophore–based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperLeukemia, Myeloid, AcuteHumansRNA Splicing FactorsMutationIonophoresPhosphoproteins

Substanzen

CopperRNA Splicing FactorsIonophoresSF3B1 protein, humanPhosphoproteins

Autor:innen und Institutionen

  • Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Research and Development, Bristol Myers Squibb Company, Cambridge, MA, USA.
  • Department of Chemistry, Université de Montréal, Montréal, Canada.
  • Division of Hematology-Oncology and Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, Canada.
  • Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.

ORCID-Profile: Céline Moison, Simon Fortier, Isabel Boivin, Rodrigo Mendoza-Sanchez, Tara MacRae, Nadine Mayotte, Eric Bonneil, Pierre Thibault, Josée Hébert, Anne Marinier, Guy Sauvageau

Zitieren

APA

Moison, C., Gracias, D., Schmitt, J., Girard, S., Spinella, J. F., Fortier, S., Boivin, I., Mendoza-Sanchez, R., Thavonekham, B., MacRae, T., Mayotte, N., Bonneil, E., Wittman, M., Carmichael, J., Ruel, R., Thibault, P., Hébert, J., Marinier, A., & Sauvageau, G. (2024). SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia. Science Advances, 10(12). https://doi.org/10.1126/sciadv.adl4018

Vancouver

Moison C, Gracias D, Schmitt J, Girard S, Spinella JF, Fortier S, et al. SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia. Science Advances. 2024;10(12). doi:10.1126/sciadv.adl4018

BibTeX
@article{Moison2024,
  author = {Moison, Céline and Gracias, Deanne and Schmitt, Julie and Girard, Simon and Spinella, Jean-François and Fortier, Simon and Boivin, Isabel and Mendoza-Sanchez, Rodrigo and Thavonekham, Bounkham and MacRae, Tara and Mayotte, Nadine and Bonneil, Eric and Wittman, Mark and Carmichael, James and Ruel, Réjean and Thibault, Pierre and Hébert, Josée and Marinier, Anne and Sauvageau, Guy},
  title = {SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {12},
  doi = {10.1126/sciadv.adl4018}
}
Kostenlos starten →